Paula Rezende-Teixeira

Dr. Paula Rezende-Teixeira

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2014 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
ENEvandro Luís Niero
Evandro Luís Niero
BRBianca Rocha-Sales
Bianca Rocha-Sales
CLCamila Lauand
Camila Lauand
BCBeatriz Araujo Cortez
Beatriz Araujo Cortez
MSMarcelo Medina de Souza
Marcelo Medina de Souza
GMGlaucia Maria Machado-Santelli
Glaucia Maria Machado-Santelli
Some cancers like melanoma and pancreatic and ovarian cancers, for example, commonly display resistance to chemotherapy, and this is the major obstacle to a better prognosis of patients. Frequently, literature presents studies in monolayer cell cultures, 3D cell cultures or in vivo studies, but rarely the same work compares results of drug resistance in different models. Several of these works are presented in this review and show that usually cells in 3D culture are more resistant to drugs than monolayer cultured cells due to different mechanisms. Searching for new strategies to sensitize different tumors to chemotherapy, many methods have been studied to understand the mechanisms whereby cancer cells acquire drug resistance. These methods have been strongly advanced along the years and therapies using different drugs have been increasingly proposed to induce cell death in resistant cells of different cancers. Recently, cancer stem cells (CSCs) have been extensively studied because they would be the only cells capable of sustaining tumorigenesis. It is believed that the resistance of CSCs to currently used chemotherapeutics is a major contributing factor in cancer recurrence and later metastasis development. This review aims to appraise the experimental progress in the study of acquired drug resistance of cancer cells in different models as well as to understand the role of CSCs as the major contributing factor in cancer recurrence and metastasis development, describing how CSCs can be identified and isolated.

30 April 2013 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
CLCamila Lauand
Camila Lauand
PRPaula Rezende-Teixeira
Paula Rezende-Teixeira
BCBeatriz Araújo Cortez
Beatriz Araújo Cortez
ENEvandro Luís de Oliveira Niero
Evandro Luís de Oliveira Niero
GMGlaucia Maria Machado-Santelli
Glaucia Maria Machado-Santelli
Background: Lung cancer often exhibits molecular changes, such as the overexpression of the ErbB1 gene. ErbB1 encodes epidermal growth factor receptor (EGFR), a tyrosine kinase receptor, involved mainly in cell proliferation and survival. EGFR overexpression has been associated with more aggressive disease, poor prognosis, low survival rate and low response to therapy. ErbB1 amplification and mutation are associated with tumor development and are implicated in ineffective treatment. The aim of the present study was to investigate whether the ErbB1 copy number affects EGFR expression, cell proliferation or cell migration by comparing two different cell lines.Methods: The copies of ErbB1 gene was evaluated by FISH. Immunofluorescence and Western blotting were performed to determine location and expression of proteins mentioned in the present study. Proliferation was studied by flow cytometry and cell migration by wound healing assay and time lapse.Results: We investigated the activation and function of EGFR in the A549 and HK2 lung cancer cell lines, which contain 3 and 6 copies of ErbB1, respectively. The expression of EGFR was lower in the HK2 cell line. EGFR was activated after stimulation with EGF in both cell lines, but this activation did not promote differences in cellular proliferation when compared to control cells. Inhibiting EGFR with AG1478 did not modify cellular proliferation, confirming previous data. However, we observed morphological alterations, changes in microfilament organization and increased cell migration upon EGF stimulation. However, these effects did not seem to be consequence of an epithelial-mesenchymal transition.Conclusion: EGFR expression did not appear to be associated to the ErbB1 gene copy number, and neither of these aspects appeared to affect cell proliferation. However, EGFR activation by EGF resulted in cell migration stimulation in both cell lines.

1 September 2014 in Arthropod Structure & Development
Verified
Journal Article
Closed access
ABAmanda dos Santos Brandão
Amanda dos Santos Brandão
Jonatas Bussador do AmaralJonatas Bussador do Amaral
Jonatas Bussador do Amaral
PRPaula Rezende-Teixeira
Paula Rezende-Teixeira
KHKlaus Hartfelder
Klaus Hartfelder
FSFábio Siviero
Fábio Siviero
GMGlaucia Maria Machado-Santelli
Glaucia Maria Machado-Santelli

7 June 2008 in Chromosome Research
Verified
Journal Article
Closed access
PDF file
PRPaula Rezende-Teixeira
Paula Rezende-Teixeira
FSFábio Siviero
Fábio Siviero
ABAmanda S. Brandão
Amanda S. Brandão
RSRoberto Vicente Santelli
Roberto Vicente Santelli
GMGlaucia Maria Machado-Santelli
Glaucia Maria Machado-Santelli

19 August 2007 in Genetica
Verified
Journal Article
Closed access
PDF file
PRPaula Rezende-Teixeira
Paula Rezende-Teixeira
FSFábio Siviero
Fábio Siviero
AAAlexandre Andrade
Alexandre Andrade
RSRoberto Vicente Santelli
Roberto Vicente Santelli
GMGlaucia Maria Machado-Santelli
Glaucia Maria Machado-Santelli

12 April 2024 in Journal of Ethnopharmacology
Verified
Journal Article
Open access
Luciana R. TalliniLuciana R. Tallini
Luciana R. Tallini
GNGustavo Neves
Gustavo Neves
MVMaria Helena Vendruscolo
Maria Helena Vendruscolo
PRPaula Rezende-Teixeira
Paula Rezende-Teixeira
WBWarley Borges
Warley Borges
JZJosé Angelo Silveira Zuanazzi
José Angelo Silveira Zuanazzi
Ethnopharmacology relevance: The plants of Amaryllidaceae family, such as Amaryllis belladonna L., have been used as herbal remedies for thousands of years to address various disorders, including diseases that might today be identified as cancer. Aim of the study: The objective of this work was to evaluate the potential of three Amaryllidaceae alkaloids against four cancer cell lines. Material and methods: The alkaloids lycorine, 1-O-acetylcaranine, and montanine were evaluated in vitro against colon adenocarcinoma cell line (HCT-116) and breast carcinoma cell lines (MCF-7, MDAMB231, and Hs578T). Computational experiments (target prediction and molecular docking) were conducted to gain a deeper comprehension of possible interactions between these alkaloids and potential targets associated with these tumor cells. Results: Montanine presented the best results against HCT-116, MDAMB231, and Hs578T cell lines, while lycorine was the most active against MCF-7. In alignment with the target prediction outcomes and existing literature, four potential targets were chosen for the molecular docking analysis: CDK8, EGFR, ER-alpha, and dCK. The docking scores revealed two potential targets for the alkaloids with scores similar to co-crystallized inhibitors and substrates: CDK8 and dCK. A visual analysis of the optimal docked configurations indicates that the alkaloids may interact with some key residues in contrast to the other docked compounds. This observation implies their potential to bind effectively to both targets. Conclusions: In vitro and in silico results corroborate with data literature suggesting the Amaryllidaceae alkaloids as interesting molecules with antitumoral properties, especially montanine, which showed the best in vitro results against colorectal and breast carcinoma. More studies are necessary to confirm the targets and pharmaceutical potential of montanine against these cancer cell lines.